These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17222660)

  • 1. Cost-utility analysis of treatment algorithms for moderate grade vesicoureteral reflux using Markov models.
    Hsieh MH; Swana HS; Baskin LS; Meng MV
    J Urol; 2007 Feb; 177(2):703-9; discussion 709. PubMed ID: 17222660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental preferences in the management of vesicoureteral reflux.
    Ogan K; Pohl HG; Carlson D; Belman AB; Rushton HG
    J Urol; 2001 Jul; 166(1):240-3. PubMed ID: 11435878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years.
    Lorenzo AJ; Pippi Salle JL; Barroso U; Cook A; Grober E; Wallis MC; Bägli DJ; Khoury AE
    J Urol; 2006 Oct; 176(4 Pt 2):1851-5. PubMed ID: 16945671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and cost analysis of pyeloplasty for antenatally diagnosed ureteropelvic junction obstruction using Markov models.
    Hsieh MH; Meng MV; Baskin LS
    Urology; 2008 Oct; 72(4):794-9. PubMed ID: 18674802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of the treatment of vesicoureteral reflux: a computer model.
    Mathews R; Naslund M; Docimo S
    J Urol; 2000 Feb; 163(2):561-6; discussion 566-7. PubMed ID: 10647685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicoureteral reflux and ureteroceles.
    Pohl HG; Joyce GF; Wise M; Cilento BG
    J Urol; 2007 May; 177(5):1659-66. PubMed ID: 17437779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prophylaxis in vesicoureteral reflux.
    Faust WC; Pohl HG
    Curr Opin Urol; 2007 Jul; 17(4):252-6. PubMed ID: 17558268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New contralateral vesicoureteral reflux after endoscopic correction of unilateral reflux--is routine contralateral injection indicated at initial treatment?
    Menezes M; Mohanan N; Haroun J; Colhoun E; Puri P
    J Urol; 2007 Oct; 178(4 Pt 2):1711-3. PubMed ID: 17707017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic treatment of vesicoureteral reflux with collagen: preliminary report and cost analysis.
    Leonard MP; Decter A; Mix LW; Johnson HW; Coleman GU
    J Urol; 1996 May; 155(5):1716-20. PubMed ID: 8627868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicoscopic cross-trigonal ureteral reimplantation: a minimally invasive option for repair of vesicoureteral reflux.
    Canon SJ; Jayanthi VR; Patel AS
    J Urol; 2007 Jul; 178(1):269-73; discussion 273. PubMed ID: 17499791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational model for predicting the chance of early resolution in children with vesicoureteral reflux.
    Knudson MJ; Austin JC; Wald M; Makhlouf AA; Niederberger CS; Cooper CS
    J Urol; 2007 Oct; 178(4 Pt 2):1824-7. PubMed ID: 17707424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mound calcification after endoscopic treatment of vesicoureteral reflux with autologous chondrocytes--a normal variant of mound appearance?
    Gargollo PC; Paltiel HJ; Rosoklija I; Diamond DA
    J Urol; 2009 Jun; 181(6):2702-7; discussion 2707-8. PubMed ID: 19375743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of ureteral dilation rate in the success of endoscopic correction of vesicoureteral reflux in pediatric patients].
    Argibay IS; Molina Vázquez E; Vela Nieto D
    Arch Esp Urol; 2008 Mar; 61(2):185-90. PubMed ID: 18491734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability of a single successful endoscopic polytetrafluoroethylene injection for primary vesicoureteral reflux: 14-year followup results.
    Yücel S; Tarcan T; Simşek F
    J Urol; 2007 Jul; 178(1):265-8; discussion 268. PubMed ID: 17499781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux.
    Knudson MJ; Austin JC; McMillan ZM; Hawtrey CE; Cooper CS
    J Urol; 2007 Oct; 178(4 Pt 2):1684-8. PubMed ID: 17707023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial.
    Pennesi M; Travan L; Peratoner L; Bordugo A; Cattaneo A; Ronfani L; Minisini S; Ventura A;
    Pediatrics; 2008 Jun; 121(6):e1489-94. PubMed ID: 18490378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children.
    Elder JS; Peters CA; Arant BS; Ewalt DH; Hawtrey CE; Hurwitz RS; Parrott TS; Snyder HM; Weiss RA; Woolf SH; Hasselblad V
    J Urol; 1997 May; 157(5):1846-51. PubMed ID: 9112544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoscopic treatment of primary vesicoureteral reflux in childhood. Review of 989 cases in a 9 years period].
    Nortes Cano L; Zambudio Carmona G; Guirao Piñera MJ; Ruiz Jiménez JI
    Cir Pediatr; 2008 Jul; 21(3):173-80. PubMed ID: 18756873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic management of vesicoureteral reflux in women presenting with pyelonephritis.
    Okeke Z; Fromer D; Katz MH; Reiley EA; Hensle TW
    J Urol; 2006 Nov; 176(5):2219-21. PubMed ID: 17070296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.